Page last updated: 2024-10-22

albuterol and Basal Ganglia Diseases

albuterol has been researched along with Basal Ganglia Diseases in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farine, K1
Yannotti, S1
Ginestet, D1

Other Studies

1 other study available for albuterol and Basal Ganglia Diseases

ArticleYear
[Preliminary report on the neuropsychological study of women treated by beta-mimetic drugs in a gynecological clinic].
    L'Encephale, 1977, Volume: 3, Issue:4

    Topics: Abortion, Threatened; Adult; Albuterol; Basal Ganglia Diseases; Female; Humans; Isoxsuprine; Pregnan

1977